Journal article
Characterization of major depression symptoms in multiple sclerosis patients
The journal of neuropsychiatry and clinical neurosciences, v 8(3), pp 318-323
01 Jan 1996
PMID: 8854304
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Retrospective review of affective disturbances in 238 patients with multiple sclerosis (MS) seen over a 6-month period revealed: 1) 51 patients (22%) received pharmacologic treatment for depressive symptoms during or within 4 years of the study period, and 17 (7%) received treatment for rapid mood swings; 2) among the 51 depressed patients, response rate to medication was extremely high; 3) relapse of depressive symptomatology after discontinuation of medication was also high (17/29); 4) first episodes of major depression frequently occurred during periods of MS progression or exacerbation, but first episodes also occurred during periods of relative clinical stability; 5) suicidal ideation was common (12 patients), but only 1 patient had a history of attempted suicide; and 6) side effects were tolerable in most patients.
Metrics
Details
- Title
- Characterization of major depression symptoms in multiple sclerosis patients
- Creators
- T F Scott - Drexel UniversityD AllenT R PriceH McConnellD Lang
- Publication Details
- The journal of neuropsychiatry and clinical neurosciences, v 8(3), pp 318-323
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Neurology
- Web of Science ID
- WOS:A1996VB21900010
- Scopus ID
- 2-s2.0-0029813058
- Other Identifier
- 991019167638504721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Clinical Neurology
- Neurosciences
- Psychiatry